The Lobbying Register, read carefully Epicycle

Returns

Every filed return on the register. Filter, then open any return on lobbying.ie to read it in full.

Clear all

Showing returns filed by Multiple Sclerosis Ireland .

Filed returns
57
match these filters
Matching filed returns per period 0 1 2 3 5 Jan–Apr 2016: 4 filed returns May–Aug 2016: 2 filed returns Sep–Dec 2016: 3 filed returns Jan–Apr 2017: 3 filed returns May–Aug 2017: 2 filed returns Sep–Dec 2017: 4 filed returns Jan–Apr 2018: 2 filed returns Jan–Apr 2019: 5 filed returns May–Aug 2019: 3 filed returns Sep–Dec 2019: 1 filed returns May–Aug 2020: 4 filed returns Jan–Apr 2022: 1 filed returns May–Aug 2022: 3 filed returns Sep–Dec 2022: 2 filed returns Jan–Apr 2023: 1 filed returns May–Aug 2023: 2 filed returns Sep–Dec 2023: 3 filed returns Jan–Apr 2024: 1 filed returns May–Aug 2024: 2 filed returns Sep–Dec 2024: 1 filed returns Jan–Apr 2025: 1 filed returns May–Aug 2025: 1 filed returns Jan–Apr 2026: 3 filed returns May–Aug 2026: 3 filed returns 2016 2017 2018 2019 2022 2023 2024 2025 2026
Filed returns per four-month period Click a column to list its returns.
PeriodRegistrantPolicy areaSubject, as filedOfficials namedLink
Sep–Dec 2016 Multiple Sclerosis Ireland Health Sativex - availability of licensed MS medication (Matters involving public funds) 1 On lobbying.ie
May–Aug 2016 Multiple Sclerosis Ireland Health Advocacy work regarding the MS medication Fampyra (Matters involving public funds) 1 On lobbying.ie
May–Aug 2016 Multiple Sclerosis Ireland Health Advocacy work relating to the cannabis-based MS medication Sativex (Matters involving public funds) 2 On lobbying.ie
Jan–Apr 2016 Multiple Sclerosis Ireland Health Letter to Tony O'Brien regarding availability of MS medications that are currently only available via individual hospital budgets (Matters involving public funds) 1 On lobbying.ie
Jan–Apr 2016 Multiple Sclerosis Ireland Health Question raised to the Director General of the HSE on the issue of underfunding for neurology services, via the National Patients' Forum (Matters involving public funds) 1 On lobbying.ie
Jan–Apr 2016 Multiple Sclerosis Ireland Health Communication with the HSE regarding the systems for the reimbursement of the MS medication Fampyra. (Public policy or programme) 1 On lobbying.ie
Jan–Apr 2016 Multiple Sclerosis Ireland Health Reimbursement of MS medication Sativex (Matters involving public funds) 2 On lobbying.ie

Policy areas in these returns

Public policy areaFiled returnsShareRelative to the largest
Health 57 100.0%